Advanced

AJNR - American Journal of Neuroradiology

Published ahead of print on July 10, 2008
doi: 10.3174/ajnr.A1229

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: ajnr.A1229v1 29/9/1658    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Google Scholar Articles by Rim, N.-J. Articles by Kim, S.Y. PubMed PubMed Citation Articles by Rim, N.-J. Articles by Kim, S.Y.

American Journal of Neuroradiology 29:1658-1663, October 2008
© 2008 American Society of Neuroradiology

BRAIN

Which CT Perfusion Parameter Best Reflects Cerebrovascular Reserve?: Correlation of Acetazolamide-Challenged CT Perfusion with Single-Photon Emission CT in Moyamoya Patients

N.-J. Rim^a, H.S. Kim^a, Y.S. Shin^b and S.Y. Kim^a

^a Department of Diagnostic Radiology, Ajou University School of Medicine, Gyeonggi-do, Korea
^b Department of Neurosurgery, Ajou University School of Medicine, Gyeonggi-do, Korea

Please address correspondence to Ho Sung Kim, Department of Diagnostic Radiology, Ajou University School of Medicine, Mt 5, Woncheon-dong, Yeongtong-gu, Suwon-si, Gyeonggi-do, 442-749, Korea; E-mail: J978005{at}lycos.co.kr

BACKGROUND AND PURPOSE: CT perfusion (CTP) is a more readily accessible method for evaluation of cerebral perfusion than single-photon emission CT (SPECT). We assessed whether there is any resting or drug-challenged CTP parameter correlating with cerebrovascular reserve (CVR) obtained by SPECT in Moyamoya patients.

MATERIALS AND METHODS: Normalized baseline CTP parameters and their percentage changes were calculated in 152 regions of interest (ROIs). On qualitative SPECT analysis, each ROI was classified in either the "impaired CVR" or "normal CVR" group. Quantitative CVR was calculated by using normalized SPECT values before and after acetazolamide administration. Baseline CTP parameters and their percentage changes were compared with qualitative and quantitative CVRs. Receiver operating characteristic (ROC) curve analysis defined the threshold values of CTP parameters that best predict impaired qualitative CVR.

RESULTS: The mean values of CTP parameters were significantly different between normal and impaired CVR groups. The percentage change of cerebral blood flow (pcCBF) was correlated most significantly with quantitative CVR (r = 0.89; P < .05). The correlation coefficients between the baseline CTP parameters and quantitative CVR were poor or not significant. The ROC-derived threshold values of pcCBF and mean transit time determined impaired CVR with a sensitivity of 94.4 and 85.2; specificity of 93.2 and 65.9; positive predictive value of 97.1 and 86.0; and negative predictive value of 87.2 and 64.4, respectively.

CONCLUSION: Baseline CTP parameters are not reliable for predicting impaired CVR. However, pcCBF correlated strongly with quantitative CVR; therefore, CTP evaluation for CVR in Moyamoya patients requires normalization and acetazolamide challenge.